ascopubs.org

A phase 2, randomized, open-label, multicenter study of sintilimab and anlotinib in combination with gemcitabine plus cisplatin (GemCis) as first-line therapy in patients (pts ...

A prospective, multicenter, phase II trial of albumin-paclitaxel plus cisplatin versus gemcitabine plus cisplatin in first-line treatment of advanced biliary tract tumors. This is an ASCO Meeting ...
Investopedia

Advanced Economies: Definition, 3 Main Criteria, and Statistics

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...
Investopedia

Open-End Fund: Definition, Example, Pros and Cons

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and currently holds a Life, ...
Forbes

10 Easy Bank Accounts To Open

Here’s a closer look at some of the easiest bank accounts to open. Account details and annual percentage rates (APYs) are accurate as of April 3, 2026. *Earn up to 4.00% Annual Percentage Yield (APY) ...
ascopubs.org

A phase I, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors.

A basket trial of trastuzumab deruxtecan, a HER2-targeted antibody-drug conjugate, for HER2-amplified solid tumors identified by circulating tumor DNA analysis (HERALD trial). This is an ASCO Meeting ...